What systems can TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes simplex virus) infections affect in newborns or individuals with compromised immune systems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systems Affected by TORCH Infections

TORCH infections cause multisystem disease affecting primarily the central nervous system, eyes, hematopoietic system, hepatobiliary system, cardiovascular system, and auditory system in newborns and immunocompromised individuals. 1

Central Nervous System (CNS)

The CNS is one of the most severely affected systems in TORCH infections, with potentially devastating long-term consequences:

  • Structural brain abnormalities include hydrocephalus, intracerebral calcifications (diffuse in toxoplasmosis, paraventricular in CMV), microcephaly, ventriculomegaly, intraventricular adhesions, and subependymal cysts 2, 1, 3
  • Neurologic impairment manifests as seizures, intellectual disability, developmental delays, and reduced alertness 2, 1
  • Toxoplasma encephalitis presents with focal neurological deficits (most common), though diffuse CNS disease can occur, particularly in HIV-infected children 4
  • Herpes simplex virus causes CNS disease in 35% of neonatal infections, with encephalitis occurring in 60-75% of infants with disseminated disease 2

Ocular System

Eye involvement is a hallmark feature across TORCH infections:

  • Chorioretinitis is characteristic of congenital toxoplasmosis, appearing as white retinal lesions with minimal hemorrhage and potential visual loss 2, 1
  • Retinopathy occurs in congenital rubella 5
  • Visual impairment develops in the majority of asymptomatic infants with congenital toxoplasmosis as a late sequela, with onset ranging from months to years 2, 6
  • Conjunctivitis is seen in 40% of neonates with localized herpes simplex virus infection 2

Auditory System

Hearing loss represents a major long-term complication:

  • Sensorineural hearing loss (SNHL) is a leading consequence of congenital CMV infection, accounting for up to 10% of SNHL cases in newborns, both unilateral and bilateral 7
  • Hearing impairment occurs as a late sequela in congenital toxoplasmosis 2, 6
  • Deafness is a significant clinical sign in congenital rubella 5
  • The hearing loss may be present at birth or develop later with progressive deterioration 7, 8

Hematopoietic System

Blood and bone marrow involvement causes multiple cytopenias:

  • Thrombocytopenia with bleeding and bruising is common across TORCH infections 1, 5, 8
  • Anemia occurs in congenital toxoplasmosis 2
  • Neutropenia is seen in toxoplasmosis 2
  • Petechiae and purpura are cutaneous manifestations of hematologic involvement in toxoplasmosis, rubella, and CMV infections 5

Hepatobiliary System

Liver involvement produces characteristic clinical findings:

  • Hepatosplenomegaly is a common finding in generalized TORCH infections 2, 1, 5
  • Jaundice occurs in newborns with congenital infections 2, 1, 5
  • Liver dysfunction and hyperbilirubinemia are documented complications 8
  • Hepatitis can occur in reactivated chronic toxoplasmosis among HIV-infected children 2

Cardiovascular System

Cardiac involvement varies by pathogen:

  • Congenital heart disease is a significant complication of congenital rubella 5, 8
  • Myocardial impairment occurs in TORCH infections 8
  • Cardiomyopathy/myocarditis is a less frequently observed presentation in HIV-infected children with reactivated toxoplasmosis 2

Dermatologic System

Skin manifestations provide important diagnostic clues:

  • Maculopapular rash occurs in congenital toxoplasmosis and as a mononucleosis-like syndrome in acquired infection 2
  • Vesicular lesions are present in approximately 80% of neonates with localized HSV disease but only 60% with CNS or disseminated disease 2
  • Dermal erythropoiesis is commonly seen in toxoplasmosis, rubella, and CMV infections 5
  • Oral ulcers characterize primary HSV gingivostomatitis 2

Lymphatic System

Lymph node involvement is characteristic:

  • Generalized lymphadenopathy occurs in congenital toxoplasmosis 2
  • Cervical lymphadenopathy is seen in acquired toxoplasmosis, often presenting as a mononucleosis-like syndrome 2
  • Tender submandibular lymphadenopathy accompanies primary HSV gingivostomatitis 2

Respiratory System

Pulmonary complications occur less frequently:

  • Pneumonitis is a less common presentation in HIV-infected children with reactivated toxoplasmosis 2
  • Lung involvement can occur in disseminated HSV with visceral disease 2

Gastrointestinal System

GI manifestations include:

  • Failure to thrive and diarrhea are presenting features in severe congenital infections 2
  • Esophagitis can occur in HIV-infected children with severe immunocompromise from HSV 2

Renal and Adrenal Systems

Visceral involvement in disseminated disease:

  • Kidney, spleen, and adrenal involvement occur in disseminated HSV among immunocompromised children 2

Clinical Pitfall

The majority (70-90%) of infants with congenital TORCH infections are asymptomatic at birth, yet most will develop severe late sequelae affecting multiple organ systems. 2, 6, 1 This underscores the critical importance of serologic screening during pregnancy and systematic evaluation of at-risk newborns, even in the absence of clinical symptoms at birth.

References

Guideline

TORCH Infections: Clinical Characteristics and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neurotoxoplasmosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

TORCH syndrome.

Seminars in dermatology, 1995

Guideline

Toxoplasmosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Analysis of serological findings and clinical manifestations of TORCH infections in newborns].

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2003

Related Questions

What is the role of Vancomycin and Cefepime in treating a pregnant or immunocompromised patient suspected of having a TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes) infection with possible bacterial co-infection?
What are the management guidelines for a neonate born to a mother with reactive Toxoplasmosis (TORCH), Other (TORCH), Rubella (TORCH), Cytomegalovirus (TORCH), Herpes simplex virus (HSV) infections?
What is the management approach for a non-pregnant woman with a history of spontaneous abortion who is ToRCH (Toxoplasmosis, Rubella, Cytomegalovirus (CMV), Herpes Simplex Virus (HSV)) positive?
What is TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes) syndrome?
What are the Toxoplasmosis (Toxoplasma gondii infection), Other (syphilis), Rubella, Cytomegalovirus (CMV), Herpes simplex virus (HSV), and Enterovirus infections, collectively known as TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes) infections, and what are the clinical considerations when taking a history of a newborn suspected of having one of these infections?
Is sclerotherapy (using a sclerosing agent) medically indicated for a patient with painful varicose veins of bilateral lower extremities, who has a history of Varithena (polidocanol) foam ablation and has tried conservative treatments, including compression stockings, but has unclear current vein size and severity of symptoms?
What is the best management approach for a patient with a history of atrial fibrillation (AF) who recently experienced a stroke?
What is the next line of management for a patient with hand spasms, orthopnea, hypocalcemia (calcium level: 7.0), hypomagnesemia (magnesium level: 1.5), and QT interval prolongation on electrocardiogram (ECG)?
What is the management plan for a young adult with mononucleosis (infectious mononucleosis) and spleenomegaly (enlarged spleen) due to a recent Epstein-Barr virus (EBV) infection?
What are the guidelines for using liquid lidocaine (local anesthetic) in patients with a history of heart disease, epilepsy, or allergies to local anesthetics for minor procedures?
What is the best course of action for a 67-year-old patient with right-of-center chest pain, mild dyspnea, intermittent cough, fever, and generalized body aches, who has a history of similar symptoms, no known drug allergies, no prior surgeries, and takes regular medications, but has no history of hypertension or cardiac stress tests?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.